US Physical Therapy (USPH) Stock: Buy, Sell, or Hold?
USPH - US Physical Therapy Inc
$82.60
-3.13 (-3.65%)
âŧ
5d:
-1.38%
30d:
+6.24%
90d:
+14.17%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When USPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: USPH is fairly priced but lacks strong directional signals. At 1.8% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: USPH is fairly priced but lacks strong directional signals. At 1.8% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$124.67
Based on 9.8% avg growth
INTRINSIC VALUE TODAY
$77.41
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: USPH is currently trading at $82.60, which is considered slightly high relative to its 30-day fair value range of $77.97 to $83.75. The stock's valuation (Forward PE: 24.7) is in line with its historical norms (23.4). At these levels, the market is pricing in 1.8% annual earnings growth.
Technical Outlook: Technically, USPH is in a strong uptrend. The price is currently testing key support at $81.35. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: USPH scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $97.00 (+17.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, USPH is in a strong uptrend. The price is currently testing key support at $81.35. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: USPH scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $97.00 (+17.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$77.97 -
$83.75
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
39.0%
All Signals
- BEARISH: Weak technical setup (31/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.7%)
- BULLISH: Trading below Wall St target ($97.00)
- BULLISH: Expecting earnings turnaround to 1.8% growth with 8.5% revenue growth
- WARNING: Composite score 47/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$77.97 -
$83.75
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$81.35
Resistance Level
$87.37
Current Trend
Strong Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.66
Wall Street Target
$97.00
(+17.4%)
Revenue Growth (YoY)
8.5%
Earnings Growth (YoY)
-56.5%
Profit Margin
4.0%
Valuation Premium vs History
+1.8% premium
PE vs Historical
24.7 vs 23.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.8%
(market-implied from PE analysis)
1-Year Target
$84.09
(+2%)
2-Year Target
$85.60
(+4%)
3-Year Target
$87.14
(+6%)
3-Yr Target (if PE normalizes)
(PE: 25â23)
PE COMPRESSION
$82.70
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.7, Growth: 15.6%)
$127.59
(+55%)
Base:
(SPY PE: 20.4, Growth: 15.6%)
$105.56
(+28%)
Bear:
(PE: 17.3, Growth: 15.6%)
$89.73
(+9%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (27x PE), but valuation improves significantly next year (25x PE) as earnings recover.
Forward PE: 27.25 | Forward EPS (Implied): $3.03
Bull Case
$99.74
(+21%)
Analyst growth 15.0%, PE expands to 28.6
Base Case
$82.60
(0%)
Market implied 0.0%, PE stable at 27.3
Bear Case
$63.19
(-24%)
Severe decline -15.0%, PE contracts to 24.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 02, 2026 2:20 AM ET
Data refreshes hourly during market hours. Next update: 3:20 AM
Data refreshes hourly during market hours. Next update: 3:20 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is USPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare CorporaâĻ |
STRONG BUY
22 analysts |
$285 | 58 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$454 | 46 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 54 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 45 HOLD |
|
ADUS
Addus HomeCare CorporatiâĻ |
STRONG BUY
11 analysts |
$134 | 53 HOLD |
